Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.
obesity medication
Posted inNPR
The FDA approves a new obesity pill, giving patients another option
The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form of Wegovy as an alternative to obesity drugs given by injection.
Posted inNPR
Using GLP-1s to maintain a normal weight? There are benefits and risks
Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric surgery to keep pounds from creeping back. Others may just want to lose a few pounds.
Posted inNPR
Wegovy obesity pill now available at pharmacies
Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers.
Posted inNPR
5 things to know about the new obesity pills that are on the way
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Posted inNPR
White House strikes deals for lower prices on obesity drugs
Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some limitations.
Posted inNPR
A new chapter for online sales of obesity drug alternatives tests legal limits
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, others are continuing and pushing regulatory boundaries.Â
